SCHEMBL19627160

SCHEMBL19627160

Cc1cc2c(CCO)coc2cc1F

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 0.46
▸ HTR1A P08908 2/20 0.36
▸ HTR1D P28221 2/20 0.36
▸ HTR2C P28335 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MAPT P10636 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ MTNR1A P48039 4/20 0.32
▸ MTNR1B P49286 3/20 0.32
▸ NQO2 P16083 1/20 0.32
▸ THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19627181 0.86 ALOX15 (0.60) ALOX15HTR1AHTR1DHTR2CKMT2A
SCHEMBL19627159 0.84 ALOX15 (0.43) ALOX15HTR1AHTR1DHTR2CKMT2A
SCHEMBL19611389 0.80 MTNR1A (0.40) HTR1ASMN1; SMN2HPGDKDM4EPOLB
SCHEMBL17321024 0.80 ALOX15 (0.45) ALOX15KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL19611333 0.75 MTNR1A (0.56) ALOX15MAPTTSHRMTNR1AMTNR1B
SCHEMBL5987722 0.75 ALDH1A1 (0.47) ALOX15KMT2AALDH1A1HPGDTSHR
SCHEMBL19627162 0.74 ALOX15 (0.54) ALOX15KMT2AMAPTSMN1; SMN2TSHR
SCHEMBL17321027 0.73 ALOX15 (0.45) ALOX15KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL4144098 0.73 HTR6 (0.48) HTR1AHTR1DHTR2CKDM4EMTNR1A
SCHEMBL19627153 0.73 THRB (0.50) ALOX15HTR1AHTR1DHTR2CMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11840541-B2 Opioid receptor modulators THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2023-12-12 — — US disclosed
US-20230271976-A1 OPIOID RECEPTOR MODULATORS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2023-08-31 — — US disclosed
US-20170334923-A1 OPIOID RECEPTOR MODULATORS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2017-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334923-A1 OPIOID RECEPTOR MODULATORS OPRM1, OPRL1, OPRD1 ALOX15 804/4885HTR1A 83/4885HTR1D 73/4885
US-20230271976-A1 OPIOID RECEPTOR MODULATORS OPRM1, OPRL1, OPRD1 ALOX15 916/4885HTR1A 80/4885HTR1D 89/4885
US-11840541-B2 Opioid receptor modulators OPRM1, OPRL1, OPRD1 ALOX15 804/4885HTR1A 83/4885HTR1D 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback